Bone Therapeutics Gains Approval for Studies of OA Knee Pain Therapies

Bone Therapeutics received regulatory approvals for Clinical Trial Applications for next studies of both of its lead therapeutic candidates for osteoarthritic (OA) knee pain: the pivotal JTA-004 Phase III clinical study targeting OA knee pain (Denmark) and the Phase IIb study of ALLOB allogeneic cell therapy in patients with difficult tibial...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us